Autorisation d’accès précoce refusée à la spécialité EMCITATE (tiratricol) dans l'indication « traitement de la thyrotoxicose périphérique chez les patients atteints d’un déficit en transporteur 8 de monocarboxylate (MCT8) (syndrome d’Allan-Herndon-Dudley), dès la naissance. »
See also
HAS opinions and decisions
07/08/2025
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
Lzt2BBXeF1WMz7JX
